 Home > Active Ingredient News > Antitumor Therapy > NICE UK supports Roche's ADC drug Kadcyla Enmetodo monosantia to treat HER2-positive early breast cancer

NICE UK supports Roche's ADC drug Kadcyla Enmetodo monosantia to treat HER2-positive early breast cancer

 Last Update: 2020-05-29
 Source: Internet
 Author: User

Tags

brachial lymph nodes

risk free

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Roche's antibody drug conjugal (ADC) Kadcyla (trastuzumab Emtansine, Enmetotoe) has been recommended by the National Institute for Health and Clinical Technology Optimization (NICE) to treat HER2-positive early breast cancer patientsabout 7,000 people in the UK are diagnosed with HER2-positive early stage breast cancer each yearCompared with HER2 negative, HER2 positive is closely related to tumor growth, higher risk of disease recurrence, and poor clinical efficacyNICE is considering using Kadcyla for patients who have undergone new complementary therapy, but cancer remains in the breast or surrounding lymph nodes until surgery to remove the tumourclinical trial evidence showed that Kadcyla increased the duration of disease-free conditions in patients who remained cancer cells after using yew ethane( a chemical therapy) and a new complementary therapy that targeted HER2, compared to the use of qutoberida aloneLesley Hugo,Roche's breast cancer franchise, said the decision 'means early breast cancer patients will continue to benefit from the latest advances in cancer treatment, as effective treatment at an early stage is critical to preventing recurrence.' '

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

Crocetin27876-94-4

CAS No.: 27876-94-4

$1-1.1/G FOB

Betulinic acid472-15-1

CAS No.: 472-15-1

$1-1.1/G FOB

1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane 53-19-0

CAS No.: 53-19-0

Pharmacy Grade

$100/KG EXW

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.